{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:26:56Z","timestamp":1758274016089},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.mehy.2017.09.017","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T11:46:29Z","timestamp":1506080789000},"page":"102-105","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Interleukin 35 and Hepatocyte Growth Factor; as a novel combined immune gene therapy for Multiple Sclerosis disease"],"prefix":"10.1016","volume":"109","author":[{"given":"Samira","family":"Moghadam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Erfanmanesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdolreza","family":"Esmaeilzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2017.09.017_b0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.imlet.2013.06.002","article-title":"Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors","volume":"154","author":"Kassis","year":"2013","journal-title":"Immunol Lett"},{"key":"10.1016\/j.mehy.2017.09.017_b0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40169-016-0124-3","article-title":"Evaluation of patients with multiple sclerosis using reverse nutech functional score and expanded disability status scale after human embryonic stem cell therapy","volume":"5","author":"Shroff","year":"2016","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.mehy.2017.09.017_b0015","first-page":"S18","article-title":"A review of possible herbal treatment in multiple sclerosis in traditional persian medicine","volume":"41","author":"Ghanavati","year":"2016","journal-title":"Iran J Med Sci"},{"key":"10.1016\/j.mehy.2017.09.017_b0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cellimm.2015.01.002","article-title":"Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis","volume":"293","author":"Gharibi","year":"2015","journal-title":"Cell Immunol"},{"key":"10.1016\/j.mehy.2017.09.017_b0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ene.12883","article-title":"Disease-modifying treat review of approved medications","volume":"23","author":"Torkildsen","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.mehy.2017.09.017_b0030","first-page":"28","article-title":"Immunobiology of dental tissue-derived stem cells; as a potentiated candidate for cell therapy","volume":"3","author":"Esmaeilzadeh","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.mehy.2017.09.017_b0035","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.13005\/bbra\/2377","article-title":"CCR5 as a novel cell and gene therapy strategies based on induction of resistance to HIV","volume":"13","author":"Farshbaf","year":"2016","journal-title":"Biosci, Biotechnol Res Asia"},{"key":"10.1016\/j.mehy.2017.09.017_b0040","first-page":"e1","article-title":"IL-1R2: a novel approach for gene therapy in atherosclerosis","volume":"14","author":"Ahmadi","year":"2016","journal-title":"Hypothesis J"},{"key":"10.1016\/j.mehy.2017.09.017_b0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jmhi.2012.03.007","article-title":"Introducing the immunomodulatory effects of mesenchymal stem cells in an experimental model of Beh\u00e7et\u2019s disease","volume":"6","author":"Mazaheri","year":"2012","journal-title":"J Med Hypotheses Ideas"},{"key":"10.1016\/j.mehy.2017.09.017_b0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jmhi.2014.05.002","article-title":"IL-24: a novel gene therapy candidate for immune system upregulation in Hodgkin\u2019s lymphoma","volume":"9","author":"Manesh","year":"2015","journal-title":"J Med Hypotheses Ideas"},{"key":"10.1016\/j.mehy.2017.09.017_b0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jmhi.2012.08.003","article-title":"Interleukin-25 as a candidate gene in immunogene therapy of pancreatic cancer","volume":"6","author":"Piri","year":"2012","journal-title":"J Med Hypotheses Ideas"},{"key":"10.1016\/j.mehy.2017.09.017_b0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jmhi.2013.06.002","article-title":"Overexpression of MDA-7\/IL-24 as an anticancer cytokine in gene therapy of thyroid carcinoma","volume":"8","author":"Mirzaei","year":"2014","journal-title":"J Med Hypotheses Ideas"},{"key":"10.1016\/j.mehy.2017.09.017_b0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.it.2007.03.001","article-title":"Mesenchymal stem cells: a new strategy for immunosuppression?","volume":"28","author":"Uccelli","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.mehy.2017.09.017_b0070","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nn.3109","article-title":"Hepatocyte growth factor mediates MSCs stimulated functional recovery in animal models of MS","volume":"15","author":"Bai","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.mehy.2017.09.017_b0075","first-page":"17","article-title":"Mesenchymal stem cell as a vector for gene and cell therapy strategies","volume":"6","author":"Esmaeilzadeh","year":"2015","journal-title":"Glob J Stem Cell Biol Transp"},{"key":"10.1016\/j.mehy.2017.09.017_b0080","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.mehy.2014.12.027","article-title":"Autologous Hematopoietic Stem Cells transplantation and genetic modification of CCR5 m303\/m303 mutant patient for HIV\/AIDS","volume":"84","author":"Esmaeilzadeh","year":"2015","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2017.09.017_b0085","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1196\/annals.1444.014","article-title":"Prospects of cell therapy for disorders of myelin","volume":"1142","author":"Ben-Hur","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.mehy.2017.09.017_b0090","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators","volume":"98","author":"Caplan","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.mehy.2017.09.017_b0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.imlet.2013.06.002","article-title":"Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors","volume":"154","author":"Kassis","year":"2013","journal-title":"Immunol Lett"},{"key":"10.1016\/j.mehy.2017.09.017_b0100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.autrev.2011.01.005","article-title":"Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases","volume":"10","author":"Ben-Ami","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.mehy.2017.09.017_b0105","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.neo.7900103","article-title":"HGF\/SF activates glycolysis and oxidative phosphorylation in DA3 murine mammary cancer cells","volume":"2","author":"Kaplan","year":"2000","journal-title":"Neoplasia"},{"key":"10.1016\/j.mehy.2017.09.017_b0110","series-title":"Ciba foundation symposium 212-plasminogen-related growth factors","article-title":"Met-HGF\/SF: tumorigenesis, invasion and metastasis","author":"Vande Woude","year":"1997"},{"key":"10.1016\/j.mehy.2017.09.017_b0115","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.biochi.2013.06.020","article-title":"The stem cell secretome and its role in brain repair","volume":"95","author":"Drago","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.mehy.2017.09.017_b0120","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.metabol.2007.01.003","article-title":"Predictors for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis","volume":"56","author":"Anan","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.mehy.2017.09.017_b0125","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1084\/jem.20042276","article-title":"TGF-\u03b21 maintains suppressor function and Foxp3 expression in CD4+ CD25+ regulatory T cells","volume":"201","author":"Marie","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2017.09.017_b0130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2017.09.017_b0135","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s12031-014-0443-z","article-title":"Circulating levels of interleukin-35 in patients with multiple sclerosis: evaluation of the influences of FOXP3 gene polymorphism and treatment program","volume":"55","author":"Jafarzadeh","year":"2015","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.mehy.2017.09.017_b0140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ni.2227","article-title":"The composition and signaling of the IL-35 receptor are unconventional","volume":"13","author":"Collison","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2017.09.017_b0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157436211795659955","article-title":"The hepatocyte growth factor receptor: structure, function and pharmacological targeting in cancer","volume":"6","author":"Cecchi","year":"2011","journal-title":"Curr Signal Trans Ther"},{"key":"10.1016\/j.mehy.2017.09.017_b0150","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/1758834011422556","article-title":"An overview of the c-MET signaling pathway","volume":"3","author":"Organ","year":"2011","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.mehy.2017.09.017_b0155","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00011-015-0858-1","article-title":"Adenovirus-mediated interleukin-35 gene transfer suppresses allergic airway inflammation in a murine model of asthma","volume":"64","author":"Li","year":"2015","journal-title":"Inflamm Res"},{"key":"10.1016\/j.mehy.2017.09.017_b0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/cyto.a.22205","article-title":"Human mesenchymal stem cells: from immunophenotyping by flow cytometry to clinical applications","volume":"83","author":"Nery","year":"2013","journal-title":"Cytometry Part A"},{"key":"10.1016\/j.mehy.2017.09.017_b0165","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ymthe.2005.12.008","article-title":"Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination","volume":"13","author":"DiPaolo","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.mehy.2017.09.017_b0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4172\/2157-7412.1000e130","article-title":"Novel approaches based on autologous stem cell engineering and gene-modification; evidence for the Cure of HIV\/AIDS","volume":"6","author":"Esmaeilzadeh","year":"2015","journal-title":"J Genet Syndr Gene Ther"},{"key":"10.1016\/j.mehy.2017.09.017_b0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/BME-2008-0516","article-title":"Culture medium study of human mesenchymal stem cells for practical use of tissue engineering and regenerative medicine","volume":"18","author":"Nakamura","year":"2008","journal-title":"Bio-Med Mater Eng"},{"key":"10.1016\/j.mehy.2017.09.017_b0180","doi-asserted-by":"crossref","first-page":"e15932","DOI":"10.1371\/journal.pone.0015932","article-title":"Detection of hepatocyte growth factor (HGF) ligand- c-MET receptor activation in formalin-fixed paraffin embedded specimens by a novel proximity assay","volume":"6","author":"Dua","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2017.09.017_b0185","series-title":"Mayo clinic proceedings","article-title":"Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies","author":"Wingerchuk","year":"2014"},{"key":"10.1016\/j.mehy.2017.09.017_b0190","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1089\/ars.2012.5068","article-title":"Multiple sclerosis: molecular mechanisms and therapeutic opportunities","volume":"19","author":"Miljkovic","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.mehy.2017.09.017_b0195","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"P T"},{"key":"10.1016\/j.mehy.2017.09.017_b0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12016-015-8468-9","article-title":"IL-35 and autoimmunity: a comprehensive perspective","volume":"49","author":"Choi","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.mehy.2017.09.017_b0205","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/136329","article-title":"The possible role of the novel cytokines IL-35 and IL-37 in inflammatory bowel disease","volume":"2014","author":"Li","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.mehy.2017.09.017_b0210","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.4049\/jimmunol.1600446","article-title":"IL-35 decelerates the inflammatory process by regulating inflammatory cytokine secretion and M1\/M2 macrophage ratio in psoriasis","volume":"197","author":"Zhang","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2017.09.017_b0215","doi-asserted-by":"crossref","first-page":"e33628","DOI":"10.1371\/journal.pone.0033628","article-title":"IL-35 is a novel responsive anti- inflammatory cytokine\u2014a new system of categorizing anti-inflammatory cytokines","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2017.09.017_b0220","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cyto.2015.12.013","article-title":"The hepatocyte growth factor (HGF)\u2013MET receptor tyrosine kinase signaling pathway: diverse roles in modulating immune cell functions","volume":"82","author":"Ilangumaran","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.mehy.2017.09.017_b0225","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/glia.20449","article-title":"T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNS","volume":"55","author":"Ghasemlou","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.mehy.2017.09.017_b0230","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2183\/pjab.86.588","article-title":"The discovery of Hepatocyte Growth Factor (HGF) and its significance for cell biology, life sciences and clinical medicine","volume":"86","author":"Nakamura","year":"2010","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.mehy.2017.09.017_b0235","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.biopha.2016.07.040","article-title":"N-Butylphthalide (NBP) ameliorated cerebral ischemia reperfusion-induced brain injury via HGF-regulated TLR4\/NF-\u03baB signaling pathway","volume":"83","author":"Zhang","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.mehy.2017.09.017_b0240","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejcb.2016.06.005","article-title":"MiR-124 suppresses the chemotactic migration of rat mesenchymal stem cells toward HGF by downregulating Wnt\/\u03b2-catenin signaling","volume":"95","author":"Yue","year":"2016","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.mehy.2017.09.017_b0245","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/1758834011422556","article-title":"An overview of the c-MET signaling pathway","volume":"3","author":"Organ","year":"2011","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.mehy.2017.09.017_b0250","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2012.06.008","article-title":"Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis","volume":"251","author":"Muller","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2017.09.017_b0255","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35- producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987717304048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987717304048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T00:03:29Z","timestamp":1602979409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987717304048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":51,"alternative-id":["S0306987717304048"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2017.09.017","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin 35 and Hepatocyte Growth Factor; as a novel combined immune gene therapy for Multiple Sclerosis disease","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2017.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}